226 related articles for article (PubMed ID: 21139583)
1. Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling.
Zhou W; Guo S; Gonzalez-Perez RR
Br J Cancer; 2011 Jan; 104(1):128-37. PubMed ID: 21139583
[TBL] [Abstract][Full Text] [Related]
2. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
Guo S; Gonzalez-Perez RR
PLoS One; 2011; 6(6):e21467. PubMed ID: 21731759
[TBL] [Abstract][Full Text] [Related]
3. Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation.
Gonzalez-Perez RR; Xu Y; Guo S; Watters A; Zhou W; Leibovich SJ
Cell Signal; 2010 Sep; 22(9):1350-62. PubMed ID: 20466060
[TBL] [Abstract][Full Text] [Related]
4. Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells.
Carino C; Olawaiye AB; Cherfils S; Serikawa T; Lynch MP; Rueda BR; Gonzalez RR
Int J Cancer; 2008 Dec; 123(12):2782-90. PubMed ID: 18798554
[TBL] [Abstract][Full Text] [Related]
5. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
[TBL] [Abstract][Full Text] [Related]
6. Insulin-dependent leptin expression in breast cancer cells.
Bartella V; Cascio S; Fiorio E; Auriemma A; Russo A; Surmacz E
Cancer Res; 2008 Jun; 68(12):4919-27. PubMed ID: 18559540
[TBL] [Abstract][Full Text] [Related]
7. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer.
Rene Gonzalez R; Watters A; Xu Y; Singh UP; Mann DR; Rueda BR; Penichet ML
Breast Cancer Res; 2009; 11(3):R36. PubMed ID: 19531256
[TBL] [Abstract][Full Text] [Related]
8. The nuclear factor-κB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma.
Yin Y; Si X; Gao Y; Gao L; Wang J
Oncol Rep; 2013 Jan; 29(1):34-8. PubMed ID: 23117246
[TBL] [Abstract][Full Text] [Related]
9. Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells.
Wang L; Tang C; Cao H; Li K; Pang X; Zhong L; Dang W; Tang H; Huang Y; Wei L; Su M; Chen T
Cancer Biol Ther; 2015; 16(8):1220-30. PubMed ID: 26121010
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
Zhu BH; Chen HY; Zhan WH; Wang CY; Cai SR; Wang Z; Zhang CH; He YL
World J Gastroenterol; 2011 May; 17(18):2315-25. PubMed ID: 21633597
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of inhibition of tumor angiogenesis by beta-hydroxyisovalerylshikonin.
Komi Y; Suzuki Y; Shimamura M; Kajimoto S; Nakajo S; Masuda M; Shibuya M; Itabe H; Shimokado K; Oettgen P; Nakaya K; Kojima S
Cancer Sci; 2009 Feb; 100(2):269-77. PubMed ID: 19200258
[TBL] [Abstract][Full Text] [Related]
12. Leptin induces IL-6 and IL-8 expression through leptin receptor Ob-Rb in human dental pulp fibroblasts.
Wei L; Chen Y; Zhang C; Liu M; Xiong H
Acta Odontol Scand; 2019 Apr; 77(3):205-212. PubMed ID: 30600742
[TBL] [Abstract][Full Text] [Related]
13. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts.
Cho ML; Ju JH; Kim HR; Oh HJ; Kang CM; Jhun JY; Lee SY; Park MK; Min JK; Park SH; Lee SH; Kim HY
Immunol Lett; 2007 Feb; 108(2):121-8. PubMed ID: 17182109
[TBL] [Abstract][Full Text] [Related]
15. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2).
Gonzalez RR; Cherfils S; Escobar M; Yoo JH; Carino C; Styer AK; Sullivan BT; Sakamoto H; Olawaiye A; Serikawa T; Lynch MP; Rueda BR
J Biol Chem; 2006 Sep; 281(36):26320-8. PubMed ID: 16825198
[TBL] [Abstract][Full Text] [Related]
16. Novel mechanism for obesity-induced colon cancer progression.
Birmingham JM; Busik JV; Hansen-Smith FM; Fenton JI
Carcinogenesis; 2009 Apr; 30(4):690-7. PubMed ID: 19221001
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis.
Reed JR; Leon RP; Hall MK; Schwertfeger KL
Breast Cancer Res; 2009; 11(2):R21. PubMed ID: 19393083
[TBL] [Abstract][Full Text] [Related]
18. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
[TBL] [Abstract][Full Text] [Related]
19. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages.
Basak C; Pathak SK; Bhattacharyya A; Mandal D; Pathak S; Kundu M
J Biol Chem; 2005 Feb; 280(6):4279-88. PubMed ID: 15561713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
